Chart Offers Insight on Medications for Diabetes Treatment

Jeannette Y. Wick, RPh, MBA, FASCP
Published Online: Tuesday, November 15th, 2016
For decades, clinicians relied on a limited number of drugs, including sulfonylureas and metformin, to help patients with type 2 diabetes. However, in the past 20 years, an increasing number of glucose-lowering drugs for diabetes treatment have become available.

The options come from 4 classes of drugs—dipeptidyl peptidase-4 inhibitors (DPP4I), sodium glucose cotransporter-2 inhibitors (SGLT2I), glucagon-like peptide-1 receptor agonists (GLP1RA), and pramlintide—that offer the advantage of employing new mechanisms of action.

The FDA has approved more than 20 new drugs from these classes, and including fixed-dose combination products significantly increases that number. This creates a challenge when educating patients about their diabetes and drug regimens due to the sheer amount of names and different mechanisms.

An article in the Journal of the Pakistani Medical Association presents a simple organizational schema that can help pharmacists teach others—patients, students, and other professionals—how these drugs act.

Available free of charge, the article provides a chart that divides drugs into 3 groups:
  • Insulin secretagogues, direct (sulfonylureas and meglitinides) and indirect in nature (GLP1RA and DPP4i)
  • Insulin sensitizers, direct (metformin and pioglitazone) and indirect in nature (pramlintide and bromocriptine)
  • Nutrient-load reducers, absorption inhibitors (alpha-glucosidase inhibitors, colesevelam and orlistat) and excretion enhancers (SGLT2i)

Understanding that these medications work in different ways can help clinicians and patients accept the use of more than 1 drug to address an elevated glycated hemoglobin (A1C) level and encourage rational drug use by suggesting how clinicians can prescribe synergistic combinations based on mode of action. The chart classifies drugs to help clarify whether they have similar clinical effects based on their mechanisms.

Although most drugs in these classes are pleiotropic (act on multiple systems) and have multiple mechanisms of action, the author uses the primary mode of action to place the drug class in its designated square.

The user-friendly table will be a welcome addition to counseling materials, and pharmacists can use it as the basis for a more comprehensive tool that includes drug names.



Current Issue

The Educated Patient

Bethany Rettberg, NPC
Practitioners should get a detailed medical history and conduct a thorough physical to treat sinus infections.
Jennifer L. Hofmann, MS, PA-C
Providing them with advice can improve control of the disease and reduce hospitalizations, morbidity, and unscheduled health care visits.
Emily C. Hayes, PharmD Candidate
Colds, coughs, and a relentless influx of sick patients in retail health clinics keep the health care providers who work there very busy.
Kristen Marjama, DNP, APRN-BC
Although the rate of foot and leg amputation has greatly declined over the past 2 decades, increasing awareness for macrovascular and microvascular complications of diabetes is essential because diabetes is the leading cause of lower-limb amputations in the United States.
$vacMongoViewPlus$ $vAR$
Contemporary Clinic
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
ONCLive
OTCGuide
Pharmacy Times
Specialty Pharmacy Times
Targeted Oncology
About Us
Advertise
Careers
Contact Us
Feedback
Privacy
Terms & Conditions
Pharmacy Healthcare & Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-257-0701

Copyright Contemporary Clinic 2019
Pharmacy Healthcare & Communications, LLC. All Rights Reserved.